The Privatization of Cancer
In my forthcoming article, I argue that our cancer regulatory regimes inadequately protect the public.

In my forthcoming article, I argue that our cancer regulatory regimes inadequately protect the public.
Government policy should promote entrepreneurship to address health inequities. Shaq’s work with social determinants of health shows why.
The Court’s rejection of group-level data in SFFA portends troubling implications for health equity and health policy.
Public health law needs its own long-term plan. Such a strategy must re-establish salus populi, the recognition that public health is central to law.
Racism is the public health issue of our time, after having been woefully un- or under-addressed for centuries.
Through social movement advocacy and engagement, BIPOC can create their own narrative of medical need and activism.
Racism has repeatedly stymied progress toward the good governance of necessities. Anti-racism, therefore, must be at the core of any solution.
BIPOC are either subject to hypervisibility, or medical erasure, where their medical needs are left unaddressed and ignored.
Debates exist over whether structural racism is a social determinant of health, and whether dismantling it is within the scope of public health law.
Today, medicine and the health care system embody discourses of power that rival the law. Will these discourses inevitably serve to oppress BIPOC?